Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

Raoul Herbrecht, David W. Denning, Thomas F. Patterson, John E. Bennett, Reginald E. Greene, Jörg-W. Oestmann, Winfried V. Kern, Kieren A. Marr, Patricia Ribaud, Olivier Lortholary, Richard Sylvester, Robert H. Rubin, John R. Wingard, Paul Stark, Christine Durand, Denis Caillot, Eckhard Thiel, Pranatharthi H. Chandrasekar, Michael R. Hodges, Haran T. Schlamm, Peter F. Troke, Ben de Pauw

Open source

DOI: 10.1056/nejmoa020191
Published: 2002-08-08
Container: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa020191,
  title = {Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis},
  author = {Raoul Herbrecht and David W. Denning and Thomas F. Patterson and John E. Bennett and Reginald E. Greene and Jörg-W. Oestmann and Winfried V. Kern and Kieren A. Marr and Patricia Ribaud and Olivier Lortholary and Richard Sylvester and Robert H. Rubin and John R. Wingard and Paul Stark and Christine Durand and Denis Caillot and Eckhard Thiel and Pranatharthi H. Chandrasekar and Michael R. Hodges and Haran T. Schlamm and Peter F. Troke and Ben de Pauw},
  year = {2002},
  journal = {New England Journal of Medicine},
  doi = {10.1056/nejmoa020191},
  url = {https://doi.org/10.1056/nejmoa020191}
}

RIS

TY  - JOUR
TI  - Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
AU  - Raoul Herbrecht
AU  - David W. Denning
AU  - Thomas F. Patterson
AU  - John E. Bennett
AU  - Reginald E. Greene
AU  - Jörg-W. Oestmann
AU  - Winfried V. Kern
AU  - Kieren A. Marr
AU  - Patricia Ribaud
AU  - Olivier Lortholary
AU  - Richard Sylvester
AU  - Robert H. Rubin
AU  - John R. Wingard
AU  - Paul Stark
AU  - Christine Durand
AU  - Denis Caillot
AU  - Eckhard Thiel
AU  - Pranatharthi H. Chandrasekar
AU  - Michael R. Hodges
AU  - Haran T. Schlamm
AU  - Peter F. Troke
AU  - Ben de Pauw
PY  - 2002
JO  - New England Journal of Medicine
DO  - 10.1056/nejmoa020191
UR  - https://doi.org/10.1056/nejmoa020191
ER  -

APA

Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., Sylvester, R., Rubin, R. H., Wingard, J. R., Stark, P., Durand, C., Caillot, D., Thiel, E., Chandrasekar, P. H., Hodges, M. R., Schlamm, H. T., Troke, P. F., & Pauw, B. D. (2002). Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis. New England Journal of Medicine. https://doi.org/10.1056/nejmoa020191

Source records

crossref · retrieved 2026-09-25T02:07:12.173Z